0001787306-24-000108.txt : 20240702
0001787306-24-000108.hdr.sgml : 20240702
20240702191316
ACCESSION NUMBER: 0001787306-24-000108
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240701
FILED AS OF DATE: 20240702
DATE AS OF CHANGE: 20240702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Welgus Howard G.
CENTRAL INDEX KEY: 0001801050
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39186
FILM NUMBER: 241097804
MAIL ADDRESS:
STREET 1: C/O ARCUTIS BIOTHERAPEUTICS, INC.
STREET 2: 2945 TOWNSGATE ROAD, SUITE 110
CITY: WESTLAKE VILLAGE
STATE: CA
ZIP: 91361
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arcutis Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001787306
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 812974255
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3027 TOWNSGATE ROAD
STREET 2: SUITE 300
CITY: WESTLAKE VILLAGE
STATE: CA
ZIP: 91361
BUSINESS PHONE: 805-418-5006
MAIL ADDRESS:
STREET 1: 3027 TOWNSGATE ROAD
STREET 2: SUITE 300
CITY: WESTLAKE VILLAGE
STATE: CA
ZIP: 91361
FORMER COMPANY:
FORMER CONFORMED NAME: Arcutis, Inc.
DATE OF NAME CHANGE: 20190905
4
1
wk-form4_1719961990.xml
FORM 4
X0508
4
2024-07-01
0
0001787306
Arcutis Biotherapeutics, Inc.
ARQT
0001801050
Welgus Howard G.
C/O ARCUTIS BIOTHERAPEUTICS, INC.
3027 TOWNSGATE ROAD, SUITE 300
WESTLAKE VILLAGE
CA
91361
1
0
0
0
1
Common Stock
2024-07-01
4
M
0
5681
1.6806
A
186020
D
Common Stock
2024-07-01
4
M
0
4319
1.6806
A
190339
D
Common Stock
2024-07-01
4
S
0
10000
9.3141
D
180339
D
Common Stock
24991
I
By Trust
Stock Option (right to buy)
1.6806
2024-07-01
4
M
0
5681
0
D
2029-03-13
Common Stock
5681
0
D
Stock Option (right to buy)
1.6806
2024-07-01
4
M
0
4319
0
D
2029-03-13
Common Stock
4319
6614
D
The transaction reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
The securities are held of record by The Welgus Living Trust, of which the Reporting Person is trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.
This option is fully vested.
/s/ David Topper, as Attorney-in-Fact for Howard G. Welgus
2024-07-02